Celestone Oral Syrup 0.6Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Celestone: Oral syrup (0.6mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

BETAMETHASONE (bay ta METH a sone) is a corticosteroid. It helps to reduce swelling, redness, itching, and allergic reactions. It is used to treat asthma, allergies, arthritis, Crohn's disease, and ulcerative colitis. It is also used for other conditions, like blood disorders and diseases of the adrenal glands.

In-Depth Information

Celestone 0.6mg/5ml Syrup

NDC: 000850942
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tenosynovitis, Tuberculosis Infection, Systemic Lupus Erythematosus (SLE), Pneumonitis, Rhus Dermatitis, Proteinuria, Crohn's Disease, Eczema, Congenital Adrenal Hyperplasia, Vernal Keratoconjunctivitis, Dermatitis Herpetiformis, Rheumatoid Arthritis, Nephrotic Syndrome, Rheumatic Carditis, Adrenogenital Syndrome, Idiopathic Thrombocytopenic Purpura (ITP), Pruritus, Allergic Conjunctivitis, Exfoliative Dermatitis, Laryngotracheobronchitis (croup), Laryngeal Edema Prophylaxis, Angioedema, Serum Sickness, Graves' Ophthalmopathy, Urticaria, Uveitis, Necrobiosis Lipoidica Diabeticorum, Gastroenteritis, Granuloma Annulare, Addison's Disease, Nasal Polyps, Bronchospasm Prophylaxis, Iritis, Trichinosis, Dermatomyositis, Ankylosing Spondylitis, Chronic Lymphocytic Leukemia (CLL), Herpes Zoster Ocular Infection, Chronic Obstructive Pulmonary Disease (COPD), Anterior Segment Inflammation, Contact Dermatitis, Berylliosis, Mycosis Fungoides, Anaphylaxis, Non-Hodgkin's Lymphoma (NHL), Acute Lymphocytic Leukemia (ALL), Pemphigus, Discoid Lupus Erythematosus, Postoperative Ocular Inflammation, Loeffler's Syndrome, Bursitis, Lichen Simplex, Epicondylitis, Stevens-Johnson Syndrome, Lichen Planus, Atopic Dermatitis, Corneal Ulcer, Asthma, Hypoplastic Anemia, Ulcerative Colitis, Keratitis, Keloids, Allergic Rhinitis, Chorioretinitis, Alopecia, Myasthenia Gravis, Cutaneous T-cell Lymphoma (CTCL), Sarcoidosis, Osteoarthritis, Polymyositis, Gouty Arthritis, Pityriasis Rosea, Thyroiditis, Thrombocytopenia, Psoriatic Arthritis, Multiple Sclerosis, Hodgkin's Disease, Juvenile Rheumatoid Arthritis (JRA)/juvenile Idiopathic Arthritis (JIA), Hemolytic Anemia, Hypercalcemia, Optic Neuritis, Erythroblastopenia

Sometimes used for but not FDA approved for the following conditions:
Temporal Arteritis, Multiple Myeloma, Hemangioma, Endophthalmitis, Wegener's Granulomatosis, Polychondritis, Polyarteritis Nodosa, Pulmonary Edema, Mixed Connective Tissue Disease, Churg-Strauss Syndrome

Storage Information
Avoid exposure to heat
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Celestone 0.6mg/5ml Syrup

Reported Side Effects for Celestone 0.6mg/5ml Syrup

Thinning Of Skin Incidence:
<33.0%*
Severity: SEVERE
Onset: DELAYED
Hypothalamic-pituitary-adrenal (HPA) Suppression Incidence:
<73.0%*
Severity: MODERATE
Onset: DELAYED
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Celestone

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5